Risk factors of doxorubicin-induced cardiomyopathy in non-muscle- invasive bladder cancer. Universa Medicina, [S. l.], v. 43, n. 3, p. 297–303, 2024. DOI: 10.18051/UnivMed.2024.v43.297-303. Disponível em: https://univmed.org/ejurnal/index.php/medicina/article/view/1606. Acesso em: 20 apr. 2025.